1. Home
  2. KDLY vs EVAX Comparison

KDLY vs EVAX Comparison

Compare KDLY & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KDLY
  • EVAX
  • Stock Information
  • Founded
  • KDLY 2019
  • EVAX 2008
  • Country
  • KDLY United States
  • EVAX Denmark
  • Employees
  • KDLY N/A
  • EVAX N/A
  • Industry
  • KDLY
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KDLY
  • EVAX Health Care
  • Exchange
  • KDLY NYSE
  • EVAX Nasdaq
  • Market Cap
  • KDLY 7.8M
  • EVAX 8.7M
  • IPO Year
  • KDLY 2024
  • EVAX 2021
  • Fundamental
  • Price
  • KDLY $1.25
  • EVAX $2.34
  • Analyst Decision
  • KDLY
  • EVAX Strong Buy
  • Analyst Count
  • KDLY 0
  • EVAX 3
  • Target Price
  • KDLY N/A
  • EVAX $33.33
  • AVG Volume (30 Days)
  • KDLY 55.8K
  • EVAX 6.9M
  • Earning Date
  • KDLY 02-18-2025
  • EVAX 03-26-2025
  • Dividend Yield
  • KDLY N/A
  • EVAX N/A
  • EPS Growth
  • KDLY N/A
  • EVAX N/A
  • EPS
  • KDLY N/A
  • EVAX N/A
  • Revenue
  • KDLY $2,875,400.00
  • EVAX $3,295,000.00
  • Revenue This Year
  • KDLY N/A
  • EVAX $4,845.21
  • Revenue Next Year
  • KDLY N/A
  • EVAX $30.30
  • P/E Ratio
  • KDLY N/A
  • EVAX N/A
  • Revenue Growth
  • KDLY N/A
  • EVAX N/A
  • 52 Week Low
  • KDLY $0.65
  • EVAX $2.22
  • 52 Week High
  • KDLY $4.20
  • EVAX $23.70
  • Technical
  • Relative Strength Index (RSI)
  • KDLY N/A
  • EVAX 38.89
  • Support Level
  • KDLY N/A
  • EVAX $2.22
  • Resistance Level
  • KDLY N/A
  • EVAX $4.05
  • Average True Range (ATR)
  • KDLY 0.00
  • EVAX 1.10
  • MACD
  • KDLY 0.00
  • EVAX -0.02
  • Stochastic Oscillator
  • KDLY 0.00
  • EVAX 2.11

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

Share on Social Networks: